SCHEMBL7607376

SCHEMBL7607376

CCCC(C)CN(O)C(=O)CCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 7/20 0.54
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.44
HTT P42858 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KDM4A O75164 1/20 0.43
KDM5A P29375 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
PHF8 Q9UPP1 1/20 0.43
KDM2A Q9Y2K7 1/20 0.43
KEAP1 Q14145 1/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7605182 0.92 ALOX5 (0.58) ALOX5KMT2AMEN1KDM4AKDM5A
SCHEMBL28449798 0.86 ALOX5 (0.51) ALOX5KMT2AMEN1KDM4AKDM5A
SCHEMBL14553382 0.76 ALOX5 (0.79) ALOX5KMT2AL3MBTL1KDM4AKDM5A
SCHEMBL9835783 0.75 ALOX5 (0.67) ALOX5KMT2AMEN1ALDH1A1KDM4A
SCHEMBL1373532 0.74 CPA3 (0.56) ALOX5KMT2AMEN1KDM4AKDM5A
SCHEMBL19024897 0.72 TDP1 (0.58) ALOX5KMT2AALDH1A1
SCHEMBL14958585 0.72 KMT2A (0.68) ALOX5KMT2AMEN1L3MBTL1HTT
SCHEMBL448875 0.71 ALOX5 (0.77) ALOX5KMT2AMEN1L3MBTL1HTT
SCHEMBL9427262 0.70 TSHR (0.46) KMT2AMEN1HTTALDH1A1
SCHEMBL25028176 0.70 ALDH1A1 (0.53) KMT2AMEN1L3MBTL1ALDH1A1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002514185-A 2002-05-14 JP claimed
EP-0949922-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-10-20 EP claimed
WO-1998013044-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1998-04-02 WO claimed